As of 2026-04-03, the Relative Valuation of AstraZeneca PLC (AZN.L) is 11,366.16 GBP. This relative valuation is based on P/E multiples. With the latest stock price at 15,316.00 GBP, the upside of AstraZeneca PLC based on Relative Valuation is -25.8%.
The range of the Relative Valuation is 9,180.93 - 15,077.26 GBP.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.8x | 18.6x |
| Forward P/E multiples | 20.8x - 28.4x | 25.1x |
| Fair Price | 9,180.93 - 15,077.26 | 11,366.16 |
| Upside | -40.1% - -1.6% | -25.8% |
| Date | P/E |
| 2026-04-02 | 30.34 |
| 2026-04-01 | 29.73 |
| 2026-03-31 | 29.27 |
| 2026-03-30 | 29.03 |
| 2026-03-27 | 28.38 |
| 2026-03-26 | 27.46 |
| 2026-03-25 | 27.94 |
| 2026-03-24 | 27.49 |
| 2026-03-23 | 27.26 |
| 2026-03-20 | 27.58 |
| 2026-03-19 | 27.87 |
| 2026-03-18 | 28.25 |
| 2026-03-17 | 28.56 |
| 2026-03-16 | 28.53 |
| 2026-03-13 | 28.45 |
| 2026-03-12 | 28.52 |
| 2026-03-11 | 28.59 |
| 2026-03-10 | 29.11 |
| 2026-03-09 | 28.72 |
| 2026-03-06 | 28.71 |
| 2026-03-05 | 29.41 |
| 2026-03-04 | 29.85 |
| 2026-03-03 | 29.46 |
| 2026-03-02 | 30.27 |
| 2026-02-27 | 30.76 |
| 2026-02-26 | 29.99 |
| 2026-02-25 | 30.17 |
| 2026-02-24 | 30.42 |
| 2026-02-23 | 30.45 |
| 2026-02-20 | 30.33 |
| 2026-02-19 | 30.29 |
| 2026-02-18 | 30.91 |
| 2026-02-17 | 30.73 |
| 2026-02-16 | 29.95 |
| 2026-02-13 | 29.93 |
| 2026-02-12 | 29.64 |
| 2026-02-11 | 29.26 |
| 2026-02-10 | 28.22 |
| 2026-02-09 | 27.64 |
| 2026-02-06 | 27.94 |
| 2026-02-05 | 27.75 |
| 2026-02-04 | 27.43 |
| 2026-02-03 | 27.49 |
| 2026-02-02 | 27.85 |
| 2026-01-30 | 26.90 |
| 2026-01-29 | 26.76 |
| 2026-01-28 | 26.87 |
| 2026-01-27 | 27.63 |
| 2026-01-26 | 27.31 |
| 2026-01-23 | 26.93 |